MedTrace Logo

Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation

NCT01813110 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2023-08-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess whether the marine omega-3 fatty acids can attenuate inflammatory responses to endotoxin challenge.

Conditions

  • Inflammatory Responses

Interventions

DRUG

4 g prescription omega-3 concentrate

4 g/d prescription omega-3 fatty acid concentrate taken orally for 8-12 weeks

DRUG

Placebo

olive oil

Sponsors & Collaborators

  • Pronova BioPharma

    collaborator INDUSTRY

  • Penn State University

    lead OTHER

Principal Investigators

  • Gordon Jensen, MD, PhD · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01813110 on ClinicalTrials.gov